Related Experiment Video
Updated: Mar 16, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Rui Liang1, Wei Dong2, Xiaopeng Shen1
1Department of Biology and Biochemistry, University of Houston.
This study presents an optimized protocol for gene delivery into C2C12 myoblasts, improving transfection and transduction efficiencies for studying myotonic dystrophy type 1 (DM1) and other muscle diseases.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- Myotonic dystrophy type 1 (DM1) is a prevalent muscular dystrophy.
- While animal models exist, myoblast cell models offer efficient cellular study of DM1.
- C2C12 myoblasts are valuable for myogenesis research but face transfection challenges.
Purpose of the Study:
- To develop an optimized protocol for gene delivery into C2C12 myoblasts.
- To enhance transfection and transduction efficiencies in C2C12 cells for DM1 research.
- To facilitate the creation of robust myoblast cell models for muscular dystrophy studies.
Main Methods:
- Detailed protocol for daily maintenance of C2C12 myoblasts.
- Optimized procedures for gene transfection and viral transduction into myoblasts.
- Methods for inducing myocyte differentiation in modified C2C12 cells.
Main Results:
- Achieved high transfection and transduction efficiencies in C2C12 myoblasts.
- Demonstrated consistent outcomes in myocyte differentiation.
- Established a reliable protocol for creating DM1 myoblast cell models.
Conclusions:
- The optimized protocol overcomes transfection barriers in C2C12 cells.
- This method enables efficient generation of myoblast models for DM1 research.
- The protocol is beneficial for studying DM1 and other muscular diseases at the cellular level.
More Related Videos
12:19Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin shRNA
Published on: February 12, 2020
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021